Literature DB >> 1864009

Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases.

T Matsumoto1, T Miike, K Yamaguchi, M Murakami, T Kawabe, J Yodoi.   

Abstract

The serum levels of soluble IL-2 receptor (sIL-2R), IL-4 and IgE-binding factors were examined in children with allergic diseases, and compared with those in non-allergic controls of the same age and sex. The results showed age-related decreases in the serum levels of sIL-2R and IgE-binding factors, but not in that of IL-4 in both allergic and non-allergic individuals. Significant elevation of sIL-2R was observed in sera from children with atopic eczema or history of an anaphylactic reaction to food, as compared with that in non-allergic controls. The serum concentration of IL-4 was elevated in all allergic groups, including cases of atopic eczema, bronchial asthma and anaphylaxis to food, compared with non-allergic controls, and was correlated significantly with the serum level of IgE (r = 0.59). The IgE-binding factor levels in sera from patients aged 6-10 years with bronchial asthma, or patients aged 1-5 years with a history of food anaphylaxis were elevated as compared with those in non-allergic controls of same age. There was no significant correlation between the serum levels of IgE-binding factors and IgE. Since sIL-2R is released by activated T cells, the present study is in favour of T cell activation causing allergic skin disorders. The serum levels of IL-4 as well as IgE did not differ among allergic patients of different clinical categories. The role of IgE in atopic eczema and other allergic diseases is not clearly established; however, it seems likely that IL-4 is deeply involved in the increased production of IgE seen in allergic individuals. The possible involvement of IgE-binding factors in the age-related changes of clinical manifestations in childhood allergic diseases was also discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864009      PMCID: PMC1535738          DOI: 10.1111/j.1365-2249.1991.tb05720.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Role for T cells, IL-2 and IL-6 in the IL-4-dependent in vitro human IgE synthesis.

Authors:  E Maggi; G F Del Prete; P Parronchi; A Tiri; D Macchia; P Biswas; C Simonelli; M Ricci; S Romagnani
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

Review 2.  Serum interleukin-2 receptor: clinical and biological implications.

Authors:  C H Pui
Journal:  Leukemia       Date:  1989-05       Impact factor: 11.528

3.  Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.

Authors:  T Kawabe; M Takami; M Hosoda; Y Maeda; S Sato; M Mayumi; H Mikawa; K Arai; J Yodoi
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

4.  Numerical and functional deficiency of suppressor T cells precedes development of atopic eczema.

Authors:  R K Chandra; M Baker
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

5.  Absorption of egg antigens by the gut observed by oral Prausnitz-Küstner (Walzer) reaction in atopic dermatitis.

Authors:  T Aoki; T Funai; M Kojima; J Adachi
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

6.  Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Wideman; J Y Bonnefoy; J E De Vries
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

7.  Abnormal regulation of in vitro IgE synthesis by T cells obtained from patients with atopic dermatitis.

Authors:  Z Hemady; S Gellis; M Chambers; R E Rocklin
Journal:  Clin Immunol Immunopathol       Date:  1985-05

8.  Increase of T cells bearing Fc epsilon R-associated antigen in patients with atopic asthma.

Authors:  T Matsumoto; H Takahashi; T Miike
Journal:  Ann Allergy       Date:  1987-04

9.  CD23: a multi-functional receptor/lymphokine?

Authors:  J Gordon; L Flores-Romo; J A Cairns; M J Millsum; P J Lane; G D Johnson; I C MacLennan
Journal:  Immunol Today       Date:  1989-05

10.  Monoclonal antibody (H107) inhibiting IgE binding to Fc epsilon R(+) human lymphocytes.

Authors:  N Noro; A Yoshioka; M Adachi; K Yasuda; T Masuda; J Yodoi
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

View more
  18 in total

1.  Elevated soluble CD23 levels in the sera from patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; K Kikuchi; H Ihn; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

Review 2.  CD23: novel disease marker with a split personality.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

3.  Soluble serum CD23 levels and CD23 molecule expression on intestinal epithelial cells in infants with reaginic and non reaginic cow's milk allergy.

Authors:  A Lachaux; I Grosjean; J Y Bonnefoy; D Kaiserlian
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

Review 4.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

5.  Th1/Th2 cytokine pattern in Arab children with severe asthma.

Authors:  Nasser M Al-Daghri; Majed S Alokail; Hossam M Draz; Sherif H Abd-Alrahman; Sobhy M Yakout; Mario Clerici
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  A Bansal; T Roberts; E M Hay; R Kay; R S Pumphrey; P B Wilson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

7.  IL-4 and interferon-gamma production in children with atopic disease.

Authors:  M Tang; A Kemp; G Varigos
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.

Authors:  H H Jabara; S R Brodeur; R S Geha
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

Authors:  T Matsubara; S Furukawa; T Motohashi; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

10.  Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders.

Authors:  Y Ohshima; K Katamura; M Miura; H Mikawa; M Mayumi
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.